Novel Insights into FH-associated Disease are KEAPing the Lid on Oncogenic HIF Signalling
Novel Insights into FH-associated Disease are KEAPing the Lid on Oncogenic HIF Signalling |
|
https://doi.org/10.18632/oncotarget.348
Julie Adam,
Peter J. Ratcliffe,
and Patrick J. Pollard
|
| 820-821 |
Circulating tumor cells in the cerebrospinal fluid: “tapping” into diagnostic and predictive potential
Circulating tumor cells in the cerebrospinal fluid: “tapping” into diagnostic and predictive potential |
|
https://doi.org/10.18632/oncotarget.349
Bishoy Faltas
|
| 822-822 |
Glutamate and tumor-associated epilepsy
Glutamate and tumor-associated epilepsy |
|
https://doi.org/10.18632/oncotarget.350
Harald Sontheimer
|
| 823-824 |
Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy |
|
https://doi.org/10.18632/oncotarget.352
Melanie Hoch,
and Denise Hilfiker-Kleiner
|
| 825-825 |
Microsatellite Instability in Colorectal Cancer: Time to Stop Hiding!
Microsatellite Instability in Colorectal Cancer: Time to Stop Hiding! |
|
https://doi.org/10.18632/oncotarget.353
Alex Duval,
Ada Collura,
Kevin Berthenet,
Anaïs Lagrange,
and Carmen Garrido
|
| 826-827 |
Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable” |
|
https://doi.org/10.18632/oncotarget.354
Oliver Hantschel,
Florian Grebien,
and Giulio Superti-Furga
|
| 828-829 |
FACT in Cell Differentiation and Carcinogenesis
FACT in Cell Differentiation and Carcinogenesis |
|
https://doi.org/10.18632/oncotarget.356
Fu-Kai Hsieh,
Olga I. Kulaeva,
Igor V. Orlovsky,
and Vasily M. Studitsky
|
| 830-832 |
Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells |
|
https://doi.org/10.18632/oncotarget.346
Genevieve L. Weber,
Marie-Odile Parat,
Zev A. Binder,
Gary L. Gallia,
and Gregory J. Riggins
|
| 833-849 |
Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.
Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. |
|
https://doi.org/10.18632/oncotarget.347
Olivier LaRochelle,
Sarah Bertoli,
François Vergez,
Jean Emmanuel Sarry,
Véronique Mansat-De Mas,
Sophie Dobbelstein,
Nicole Dastugue,
Anne-Claire Strzelecki,
Cindy Cavelier,
Laurent Creancier,
Arnaud Pillon,
Anna Kruczynski,
Cecile Demur,
Audrey Sarry,
Françoise Huguet,
Anne Huynh,
Christian Récher,
and Eric Delabesse
|
| 850-861 |
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo |
|
https://doi.org/10.18632/oncotarget.357
Wanglong Qiu,
Fikret Sahin,
Christine Iacobuzio-Donahue,
Dario Garcia-Carracedo,
Wendy Wang,
Chia-Yu Kuo,
Doris Chen,
Dan Arking,
Andrew Lowy,
Ralph Hruban,
Helen Remotti,
and Gloria H. Su
|
| 862-873 |
Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells
Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells |
|
https://doi.org/10.18632/oncotarget.360
Maeva Dufies,
Arnaud Jacquel,
Nathalie Belhacene,
Guillaume Robert,
Thomas Cluzeau,
Fréderic Luciano,
Jill Patrice Cassuto,
Sophie Raynaud,
and Patrick Auberger
|
| 874-885 |
ARID2: A new tumor suppressor gene in hepatocellular carcinoma
ARID2: A new tumor suppressor gene in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.355
Hong Zhao,
Jian wang,
Yongqing Han,
Zhen Huang,
Jianming Ying,
Xinyu Bi,
Jianjun Zhao,
Yi Fang,
Haitao Zhou,
Jianguo Zhou,
Zhiyu Li,
Yefan Zhang,
Xue Yang,
Tao Yan,
Linfang Wang,
Michael S Torbenson,
and Jianqiang Cai
|
| 886-891 |
